Advanced Therapies 2021 | What can the advanced therapies industry learn from the COVID-19 pandemic?

Matthew Durdy, CEO, Cell and Gene Therapy Catapult, London, UK, talks on the impact of the COVID-19 pandemic on the advanced therapies industry. Whilst the pandemic had a negative effect on the progress of clinical trials in the short-term, it raised public awareness of the importance and potential impact of scientific advancement and demonstrated the benefits of the industry working more collaboratively. He also explains how the development of advanced therapeutics could take pressure off healthcare infrastructure through the use of potentially curative treatments following a single administration, thus reducing the number hospital visits compared to standard therapies. This interview took place at the Advanced Therapies Congress & Expo 2021.